colistimethate sodium has been researched along with Respiratory Tract Infections in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abad, CLR; Li, KL | 1 |
| Bilton, D; Caine, N; Charman, SC; Kaplan, S; Lee, A | 1 |
| Cao, W; Debonnett, L; Greenwood, J; Hamed, K; Mastoridis, P; Nash, EF; Schwarz, C; Sommerwerck, U; Tamm, M | 1 |
| Clark, P; Knight, H; Nolan, K | 1 |
| Collie, D; Doherty, C; Glendinning, L; Govan, J; McLachlan, G; Tennant, P; Thornton, E; Wright, S | 1 |
| Balayn, D; Couet, W; Gobin, P; Grégoire, N; Jacobs, M; Marchand, S; Mégarbane, B; Mimoz, O | 1 |
| Cardoso, DE; Carrilho, CM; Falci, DR; Levin, AS; Lopes, NT; Oliveira, MS; Perdigão-Neto, LV; Rigatto, MH; Tanita, MT; Tuon, FF; Zavascki, AP | 1 |
| Assous, MV; Ben-Chetrit, E; Katz, DE; Marchaim, D; Wiener-Well, Y; Yinnon, A | 1 |
| Angyalosi, G; Balp, MM; Capkun-Niggli, G; Doering, G; Higashi, K; Jansen, JP; Littlewood, KJ; Tiddens, HA | 1 |
| NIXON, M; RODGER, KC; TONNING, HO | 1 |
1 review(s) available for colistimethate sodium and Respiratory Tract Infections
| Article | Year |
|---|---|
A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Load; Bayes Theorem; Biological Availability; Chronic Disease; Colistin; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Information Services; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Tobramycin; Treatment Outcome | 2012 |
1 trial(s) available for colistimethate sodium and Respiratory Tract Infections
| Article | Year |
|---|---|
Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Child; Colistin; Cross-Over Studies; Cystic Fibrosis; Equipment Contamination; Equipment Design; Europe; Female; Forced Expiratory Volume; Humans; Lung; Male; Nebulizers and Vaporizers; Patient Satisfaction; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Time Factors; Tobramycin; Treatment Outcome; Young Adult | 2017 |
8 other study(ies) available for colistimethate sodium and Respiratory Tract Infections
| Article | Year |
|---|---|
The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Meropenem; Middle Aged; Organ Dysfunction Scores; Philippines; Respiratory Tract Infections; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Young Adult | 2020 |
Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Colistin; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Registries; Respiratory Tract Infections; Symptom Flare Up; United Kingdom | 2021 |
NICE guidance on colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Clinical Trials as Topic; Colistin; Cystic Fibrosis; Drug Monitoring; Drug Therapy, Combination; Dry Powder Inhalers; Humans; Practice Guidelines as Topic; Pseudomonas Infections; Respiratory Function Tests; Respiratory Tract Infections; State Medicine; Tobramycin; United Kingdom | 2013 |
Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; Chronic Disease; Colistin; Disease Models, Animal; Female; Injections, Intravenous; Lung; Male; Microbiota; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sheep, Domestic | 2015 |
Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Renal Dialysis; Respiratory Tract Infections | 2016 |
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
Topics: Acute Kidney Injury; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Colistin; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Intraabdominal Infections; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Polymyxin B; Prospective Studies; Respiratory Tract Infections; Risk Factors; Survival Analysis | 2016 |
Ten years with colistin: a retrospective case series.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Colistin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Retrospective Studies; Urinary Tract Infections | 2016 |
TREATMENT OF INFECTIONS WITH COLISTIMETHATE SODIUM (COLY-MYCIN).
Topics: Colistin; Drug Therapy; Enterobacter; Escherichia coli; Escherichia coli Infections; Geriatrics; Humans; Proteus; Pseudomonas Infections; Respiratory Tract Infections; Toxicology; Urinary Tract Infections | 1965 |